ISSN 1300-4948 | E-ISSN 2148-5607
RELATED ARTICLES
Editorial
Anadoluda anne ve bebeklerinde Helikobakter pilori enfeksiyonu
(Turk J Gastroenterol 2010; 21: 113-118)
DOI: 10.4318/tjg.2010.0067
Is there any relationship between Behçet's disease and hepatit C virus?
(Turk J Gastroenterol 1998; 9: 10-13)
Effects of Giardia lamblia infestation on the clinical sourse of cronic hepatitis B
(Turk J Gastroenterol 1998; 9: 24-27)
Acral erythema induced bu interferon alpha in a child
(Turk J Gastroenterol 1998; 9: 70-72)
Hepatitis C infection in non-Hodgkin's lymphoma
(Turk J Gastroenterol 1998; 9: 73-75)
Hepatitis C virus and deep abdominal lymphadenopathy
(Turk J Gastroenterol 1998; 9: 91-94)
Effect of anti-HCV positifity on response to hepatitis B virus vaccine in haemodialysis patients
(Turk J Gastroenterol 1998; 9: 105-107)
Transient sinus bradycardia in a child during the course of acute hepatitis A
(Turk J Gastroenterol 2007; 18: 195-197)
Pegylated interferon treatment of acute pericarditis associated with acute hepatitis C
(Turk J Gastroenterol 2007; 18: 268-271)
The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: An analysis of clinical studies
(Turk J Gastroenterol 2006; 17: 25-34)
Daily consensus interferon (CIFN) monotherapy in non-responders or relapsers to a previous interferon regime: One year follow-up after 48 weeks of treatment
(Turk J Gastroenterol 2006; 17: 35-39)
The efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in chronic hepatitis C patients
(Turk J Gastroenterol 2006; 17: 79-83)
The efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in chronic hepatitis C patients
(Turk J Gastroenterol 2006; 17: 94-98)
Hepatitis A and parvovirus B19 infections in an infant with fulminant hepatic failure
(Turk J Gastroenterol 2006; 17: 148-150)
An asymptomatic huge hepatocellular carcinoma with intra-atrial tumor thrombus in a patient with chronic hepatitis B viral infection
(Turk J Gastroenterol 2006; 17: 203-205)
Assessment of bone metabolism and mineral density in chronic viral hepatitis
(Turk J Gastroenterol 2006; 17: 260-266)
Hepatitis B and C virus in West-Central Turkey: Seroprevalence in healthy individuals admitted to a university hospital for routine health checks
(Turk J Gastroenterol 2006; 17: 267-272)
P21 expression and its relation to disease activity and hepatocyte proliferation in chronic hepatitis B virus infection
(Turk J Gastroenterol 2005; 16: 12-16)
Chronic hepatitis delta virus infection in Van region of eastern Turkey
(Turk J Gastroenterol 2005; 16: 17-20)
The coexistence of hepatitis A and infectious mononucleosis
(Turk J Gastroenterol 2005; 16: 102-104)
Determination of hepatitis B genotypes in patients with chronic hepatitis B virus infection in Turkey
(Turk J Gastroenterol 2005; 16: 183-187)
Immunomodulatory effects of HBsAg vaccine and levamisole in chronic hepatitis B and hepatitis B carrier children
(Turk J Gastroenterol 2005; 16: 188-193)
The quality of life in hemodialysis patients with chronic hepatitis C virus infection
(Turk J Gastroenterol 2009; 20: 243-246)
DOI: 10.4318/tjg.2009.0020
Prevelance and genotyping of hepatitis C virus RNA in Turkish patinets with non-A, non-B liver disease
(Turk J Gastroenterol 1998; 9: 208-212)
The prevalence of hepatocellular carcinoma in patients with liver cirrhosis in Southeastern Turkey
(Turk J Gastroenterol 1998; 9: 217-220)
Lamivudine resistance in untreated chronic hepatitis B patients in Turkey
(Turk J Gastroenterol 2008; 19: 99-103)
Daily use of consensus interferon: One-year treatment results for chronic hepatitis C patients relapsing ornon-responding to previous interferon
(Turk J Gastroenterol 2000; 11: 191-195)
Effect of interferon treatment on glucose metabolism in children with chronic hepatitis B infection
(Turk J Gastroenterol 2004; 15: 4-10)
Hepatitis B carriage and Brucella seroprevalence in urban and rural areas of Bolu province of Turkey: A prospective epidemiologic study
(Turk J Gastroenterol 2004; 15: 11-13)
A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels
(Turk J Gastroenterol 2004; 15: 14-20)
The mutations in ISDR of NS5A gene are not associated with response to interferon treatment in Turkish patients with chronic hepatitis C virus genotype lb infection
(Turk J Gastroenterol 2004; 15: 21-26)
Lichen planus and HCV infection in Turkish patients
(Turk J Gastroenterol 2004; 15: 133-136)
*Changes in the seroepidemiological pattern of Helicobacter pylori infection over the last 10 years in Turkey
(Turk J Gastroenterol 2004; 15: 156-158)
Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha
(Turk J Gastroenterol 2004; 15: 213-218)
Predictive value of proliferating cell nuclear antigen index in response to interferon treatment in patients with chronic viral hepatitis B and C
(Turk J Gastroenterol 2001; 12: 89-94)
Seroepidemiology of delta hepatitis in Turkey
(Turk J Gastroenterol 1999; 10: 316-327)
Hepatitis B seroprevalance and risk factors in urban areas of Malatya
(Turk J Gastroenterol 2002; 13: 1-5)
The effect of recombinant hepatitis B vaccine therapy in chronic hepatitis B infection
(Turk J Gastroenterol 2002; 13: 6-10)
Alanine aminotransferase deficiency in a hepatitis B surface antigen positive patient presenting with acute hepatitis
(Turk J Gastroenterol 2002; 13: 60-62)
Acute oligo-anuric renal failure during the course of non-fulminant hepatitis A in a patient with anorexia nervosa
(Turk J Gastroenterol 2002; 13: 164-167)
Chronic hepatitis C with mixed cryoglubulinemia: A cade report
(Turk J Gastroenterol 1996; 7: 254-256)
Dietary nitrate and nitrite levels in an endemic upper gastrointestinal (esophageal and gastric) cancer region of Turkey
(Turk J Gastroenterol 2003; 14: 50-53)
Clinicopathologic features and risk factors for hepatocellular carcinoma: Results from a single center in southern Turkey
(Turk J Gastroenterol 2003; 14: 85-90)
Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: Clinical significance and correlation with serological markers
(Turk J Gastroenterol 2003; 14: 157-163)
Type 1 gastric carcinoid tumor: another extrahepatic manifestation of hepatitis C virus infection?
(Turk J Gastroenterol 2003; 14: 194-196)
A case of autoimmune hepatitis and autoimmune hemolytic anemia following hepatitis A infection
(Turk J Gastroenterol 2003; 14: 204-207)
A comparative immunohistochemical study of HBsAg, HBcAg and CD57 in chronic hepatitis B pediatric patients with and without malignant disorders
(Turk J Gastroenterol 2003; 14: 234-238)
Evaluation of the outcome of interferon therapy in chronic hepatitis B infection
(Turk J Gastroenterol 1999; 10: -)
Autoantibodies in chronic viral hepatitis and autoimmune hepatitis
(Turk J Gastroenterol 1997; 8: 381-384)
Importance of second and third generation ELISA test in detection of HVC antibody
(Turk J Gastroenterol 1997; 8: 144-147)
Response to hepatitis B vaccine in patients with non-hepatitis B chronic liver disease
(Turk J Gastroenterol 1997; 8: 148-151)
Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: A population-based study
(Turk J Gastroenterol 2009; 20: 27-30)
Transmission routes of chronic hepatitis C and their relation to HCV genotypes
(Turk J Gastroenterol 2010; 21: 396-400)
DOI: 10.4318/tjg.2010.0126
Determination of intracellular Th1/Th2 type cytokines in lymphocytes of chronic hepatitis B patients treated with interferon-alpha
(Turk J Gastroenterol 2010; 21: 401-410)
DOI: 10.4318/tjg.2010.0127
Detection of HEV antibody seroprevalance in HAV antibody positive subjects
(Turk J Gastroenterol 1999; 10: 232-235)
Relationship between serum levels of interleukin-10, interleukin-2 and soluble intercellular adhesion molecule-I and liver injury in chronic hepatitis B virus infection
(Turk J Gastroenterol 1999; 10: 243-248)
HCV genotypes in HCV related chronic hepatitis in Southeast Anatolia
(Turk J Gastroenterol 1999; 10: 249-252)
Review
Show Me Echo – Hepatitis C: A telemedicine mentoring program for patients with hepatitis C in underserved and rural areas in Missouri as a model in developing countries
(Turk J Gastroenterol 2015; 26: 447-449)
DOI: 10.5152/tjg.2015.159000
Emerging therapeutics and relevant targets for chronic Hepatitis B
(Turk J Gastroenterol 2016; 27: 210-215)
DOI: 10.5152/tjg.2016.15521
Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report
(Turk J Gastroenterol 2018; 29: 259-269)
DOI: 10.5152/tjg.2018.18263
New modalities in the treatment of HCV in pre and post - transplantation setting
(Turk J Gastroenterol 2015; 26: 204-213)
DOI: 10.5152/tjg.2015.0204
Case Report
A case of entecavir resistance which is developed after complete viral suppression during entecavir treatment for nucleoside-naive chronic hepatitis B
(Turk J Gastroenterol 2014; 25: 206-209)
DOI: 10.5152/tjg.2014.3605
Definition of C282Y mutation in a hereditary hemochromatosis family from Turkey
(Turk J Gastroenterol 2007; 18: 53-57)
A case of gynecomastia due to entecavir
(Turk J Gastroenterol 2010; 21: 313-316)
DOI: 10.4318/tjg.2010.0108
Immune thrombocytopenic purpura as sole manifestation in a case of acute hepatitis A
(Turk J Gastroenterol 2005; 16: 217-219)
A case of entecavir-associated bullous fixed drug eruption and a review of literature
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.17887
Original Article
Epidemiological shift of hepatitis A in central Adana, Turkey
(Turk J Gastroenterol 2014; 25: 6-8)
DOI: 10.5152/tjg.2014.4163
Fatty liver disease might increase the risk of abdominal operation in patients with fatty liver and the prevalence of cancer in first-degree relatives
(Turk J Gastroenterol 2014; 25: 138-141)
DOI: 10.5152/tjg.2014.7674
Relation between serum quantitative HBsAg, ALT and HBV DNA levels in HBeAg negative chronic HBV infection
(Turk J Gastroenterol 2014; 25: 142-146)
DOI: 10.5152/tjg.2014.5711
Gallstones in liver transplant recipients: A single-center study in China
(Turk J Gastroenterol 2015; 26: 429-434)
DOI: 10.5152/tjg.2014.6344
AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B
(Turk J Gastroenterol 2012; 23: 353-358)
DOI: 10.4318/tjg.2012.0348
Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B
(Turk J Gastroenterol 2012; 23: 247-252)
DOI: 10.4318/tjg.2012.0380
Serum complement C4 in chronic hepatitis C: Correlation with histopathologic findings and disease activity
(Turk J Gastroenterol 2012; 23: 33-37)
DOI: 10.4318/tjg.2012.0310
Investigation of ErbB-2 Overexpression on Patients with Gastric Cancer in Eastern Anatolia of Turkey
(Turk J Gastroenterol 2013; 24: 211-217)
DOI: 10.4318/tjg.2013.0641
Prevelance of hepatitis D co-enfection in children with hepatitis B infection: Cross-sectional analyses from Western Turkey
(Turk J Gastroenterol 2013; 24: 345-348)
DOI: 10.4318/tjg.2013.0681
Possible transmission risks and genotype distribution of hepatitis C virus infection in Western Turkey
(Turk J Gastroenterol 2013; 24: 349-355)
DOI: 10.4318/tjg.2013.0518
Simple non-invasive markers as a predictor of fibrosis and viral response in chronic hepatitis C patients
(Turk J Gastroenterol 2012; 23: 538-545)
DOI: 10.4318/tjg.2012.0358
Risk factors for higher anti-HCV positivity in a border city in southern Turkey with unique population characteristics
(Turk J Gastroenterol 2012; 23: 574-579)
DOI: 10.4318/tjg.2012.0554
Molecular characterization of hepatitis A virus isolated from acute infections in Turkey
(Turk J Gastroenterol 2012; 23: 714-719)
DOI: 10.4318/tjg.2012.0450
The impact of hepatitis C virus infection on long-term outcome in renal transplant patients
(Turk J Gastroenterol 2011; 22: 165-170)
DOI: 10.4318/tjg.2011.0236
AST-platelet ratio index, Forns index and FIB-4 in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis C
(Turk J Gastroenterol 2011; 22: 279-285)
DOI: 10.4318/tjg.2011.0213
Characteristics of patients dying from acute viral hepatitis in Serbia
(Turk J Gastroenterol 2011; 22: 152-157)
DOI: 10.4318/tjg.2011.0184
Analysis of cases with tuberculous peritonitis: A single-center experience
(Turk J Gastroenterol 2014; 25: 72-78)
DOI: 10.5152/tjg.2014.5145
Insulin/high-density lipoprotein cholesterol ratio: A newly-discovered predictor of esophageal varices in patients with hepatitis C virus-related cirrhosis in the absence of diabetes mellitus
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.18237
Responsiveness of children with celiac disease to different hepatitis B vaccination protocols
(Turk J Gastroenterol 2011; 22: 27-31)
DOI: 10.4318/tjg.2011.0152
Impact of fatty liver on hepatitis B virus replication and virologic response to tenofovir and entecavir
(Turk J Gastroenterol 2016; 27: 42-46)
DOI: 10.5152/tjg.2015.150348
The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B
(Turk J Gastroenterol 2015; 26: 36-41)
DOI: 10.5152/tjg.2015.4636
Can eicosapentaenoic acid maintain the original ribavirin dose or affect the response during the treatment course of chronic hepatitis C virus (HCV) patients?
(Turk J Gastroenterol 2016; 27: 55-61)
DOI: 10.5152/tjg.2015.150280
Hepatitis C virus genotype distribution in Turkey remains unchanged after a decade: Performance of phylogenetic analysis of the NS5B, E1, and 5’UTR regions in genotyping efficiency
(Turk J Gastroenterol 2014; 25: 405-410)
DOI: 10.5152/tjg.2014.7083
The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C
(Turk J Gastroenterol 2016; 27: 156-164)
DOI: 10.5152/tjg.2015.150449
The association between insulin resistance and hepatic fibrosis in patients with chronic hepatitis C: An observational, multicenter study in Turkey
(Turk J Gastroenterol 2014; 25: 546-552)
DOI: 10.5152/tjg.2014.7829
Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy?
(Turk J Gastroenterol 2016; 27: 165-172)
DOI: 10.5152/tjg.2016.150300
Public awareness of hepatitis B infection in Turkey as a model of universal effectiveness in health care policy
(Turk J Gastroenterol 2014; 25: 304-308)
DOI: 10.5152/tjg.2014.6718
Evaluation of fluvastatin in combination with the standard of care therapy (PEG-IFN/Ribavirin) in Egyptian patients with hepatitis C virus
(Turk J Gastroenterol 2015; 26: 511-516)
DOI: 10.5152/tjg.2015.15806
Seroprevalence of human fascioliasis in Van province, Turkey
(Turk J Gastroenterol 2015; 26: 259-262)
DOI: 10.5152/tjg.2015.8001
Five-year results of oral antiviral therapy in HBeAg-negative chronic Hepatitis B
(Turk J Gastroenterol 2016; 27: 279-283)
DOI: 10.5152/tjg.2016.16085
Effects of mannose-binding lectin and mannose-binding lectin polymorphisms on treatment response in patients with chronic hepatitis C
(Turk J Gastroenterol 2014; 25: 702-706)
DOI: 10.5152/tjg.2014.6583
Quick Look to Guidelines
Management of special patient groups with hepatitis B virus infection: The EASL 2017 Clinical Practice Guidelines
(Turk J Gastroenterol 2017; 28: 518-521)
DOI: 10.5152/tjg.2017.171017
Gastrointestinal Tract - Original Article
Incidence patterns of colorectal cancers in four countries of the Middle East Cancer Consortium (Cyprus, Jordan, Israel, and İzmir, Turkey) compared with those in the United States Surveillance, Epidemiology, and End Results Program
(Turk J Gastroenterol 2018; 29: 36-44)
DOI: 10.5152/tjg.2018.17263
Liver - Original Article
Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.17634
Reactivation rates in patients using biological agents, with resolved HBV infection or isolated anti-HBc IgG positivity
(Turk J Gastroenterol 2018; 29: 561-565)
DOI: 10.5152/tjg.2018.18032
Assessing the outcome of patients with liver cirrhosis during hospital stay: A comparison of lymphocyte/monocyte ratio with MELD and Child-Pugh scores
(Turk J Gastroenterol 2018; 29: 308-315)
DOI: 10.5152/tjg.2018.17631
Does steatosis affect the performance of diffusion-weighted MRI values for fibrosis evaluation in patients with chronic hepatitis C genotype 4?
(Turk J Gastroenterol 2017; 28: 283-288)
DOI: 10.5152/tjg.2017.16640
Role of nucleoside/nucleotide analogues and low-dose hepatitis B immune globulin in prophylaxis of hepatitis B recurrence among cadaveric liver transplant recipients
(Turk J Gastroenterol 2018; 29: 61-66)
DOI: 10.5152/tjg.2018.17595
Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study
(Turk J Gastroenterol 2018; 29: 464-472)
DOI: 10.5152/tjg.2018.16597
Lamivudine’s efficacy and safety in preventing mother-to-child transmission of hepatitis B: A meta-analysis
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.18148
Lamivudine’s efficacy and safety in preventing of mother-to-child transmission of hepatitis B: A meta-analysis
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.18148
Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.16597
Pediatric Gastroenterology - Original Article
Prevalence of celiac disease among school-age children in Çorum, Turkey
(Turk J Gastroenterol 2018; 29: 595-600)
DOI: 10.5152/tjg.2018.18020
Prevalence of celiac disease among school-age children in Çorum, Turkey
(Turk J Gastroenterol ; : -)
DOI: 10.5152/eurjrheum.2018.18020
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2018 Turkish Society of Gastroenterology | Latest Update: 22.10.2018